newsfilter
← Latest News
PR Newswire·

Palatin Announces Exercise of Warrants for Approximately $6.1 Million Gross Proceeds

Palatin Technologies, Inc. (NYSE American: PTN) ("Palatin" or the "Company"), a biopharmaceutical company developing first-in-class medicines based...